#United States #Pasadena #Ventric Health #Vivio System #Dr. Javed Butler

Ventric Health Strengthens Clinical Advisory Board

Ventric Health, the creator of the innovative Vivio® System, has announced a significant enhancement to its Clinical Advisory Board with the appointment of esteemed cardiologists Dr. Javed Butler and Dr. Biykem Bozkurt. This strategic move is expected to greatly enhance both the clinical and commercial uptake of the Vivio System, a groundbreaking non-invasive device sanctioned by the FDA for measuring elevated left ventricular end-diastolic pressure (LVEDP).

The Vivio System stands out as the first non-invasive solution for accurately gauging LVEDP in outpatient healthcare settings, a critical step in diagnosing and managing heart failure. The addition of Dr. Butler and Dr. Bozkurt, both recognized leaders in cardiovascular medicine, will bolster Ventric Health’s commitment to delivering cutting-edge clinical solutions for heart failure detection.

Impact of New Appointments

Dr. Javed Butler brings a wealth of expertise as the President of the Baylor Scott and White Research Institute and a Senior Vice President at Baylor Scott & White Health. His rich background includes being a Distinguished Professor of Medicine at the University of Mississippi and a celebrated author with over 1,500 peer-reviewed publications. His insight into patient journeys through complex cardiac conditions will be instrumental in refining the performance and integration of Vivio within primary care frameworks.

Dr. Biykem Bozkurt, the Editor-in-Chief of JACC Journals Heart Failure, adds vital expertise to the advisory board. As a professor of medicine at Baylor College of Medicine and the director of the Winters Center for Heart Failure Research, Dr. Bozkurt’s leadership in the cardiovascular field positions her to influence the operational efficacy of the Vivio System substantially. Her collaborative approach to medicine will ensure that the system meets and exceeds clinical requirements, aiming for seamless incorporation into everyday cardiology practices.

Sean Brady, CEO of Ventric Health, emphasized the importance of these appointments, describing them as a significant endorsement of the Vivio System’s clinical potential. Brady noted, “Their deep understanding of the patient journey and the limitations of traditional diagnostic tools will be invaluable. They will help us ensure that Vivio not only meets the highest clinical standards but also seamlessly integrates into modern primary care and cardiology workflows.”

Strengthening Clinical Collaborations

With the inclusion of Dr. Butler and Dr. Bozkurt, the advisory board now features a diverse array of expertise, alongside existing members such as Dr. KellyAnn Light-McGroary, a heart failure and transplant cardiologist, and Dr. John Spertus, a prominent heart failure expert. This collective knowledge aims to align the company’s offerings with contemporary healthcare delivery models, ultimately improving heart failure outcomes for patients.

The Promise of the Vivio System

The Vivio System is designed to measure LVEDP non-invasively in less than five minutes, utilizing innovative physics-based analysis of cardiac waveforms. This expedited process at the point of care eliminates the need for imaging, referrals, or invasive procedures while providing comprehensive insight through the Kansas City Cardiomyopathy Questionnaire (KCCQ-12).

Published studies, including a significant JAHA validation in 2025 and an HFSA abstract on detecting pre-symptomatic stages, further validate its clinical relevance. The growing use of the Vivio System across primary care organizations highlights a marked improvement in patient outcomes and substantial cost savings linked to early heart failure detection.

Looking Ahead: Ventric Health’s Vision

Ventric Health remains committed to revolutionizing heart failure detection through the Vivio System. By continuously aligning with leading cardiovascular practitioners, the company ensures its products adapt to the evolving landscape of healthcare delivery. With the recent appointments to the Clinical Advisory Board, Ventric Health is poised for growth and innovation in the ever-critical sphere of cardiac healthcare, ultimately striving for improved quality of life and outcomes for patients suffering from heart conditions.

For more information about the Vivio® System and Ventric Health’s initiatives, visit their official website or reach out to their clinical team for insights on advanced heart failure detection strategies.